Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00881686

Myocardial Protection With Adenosine Preconditioning

Study of Myocardial Protection in Pediatric Cardiac Surgery With Adenosine Preconditioning

Sponsor: Xijing Hospital

Conditions Adenosine Cardiac Surgical Procedures Heart Defects, Congenital Myocardial Reperfusion Injury

Interventions adenosine

Updated 4 times since 2017 Last updated: Apr 14, 2009 Started: Jun 30, 2008 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Adenosine and Cardiac Surgical Procedures, this trial is completed. The trial is conducted by Xijing Hospital and has accumulated 4 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China